BackgroundAdipokines are involved in the pathogenesis of metabolic disorders including obesity and type 2 diabetes mellitus (T2DM). This study investigates the levels of leptin, resistin, visfatin, secreted frizzled-related protein 5 (SFRP5), monocyte chemoattractant protein-1 (MCP-1) and retinol-binding protein 4 (RBP4) and their correlations with clinical parameters of overweight and T2DM.MethodsWe recruited overweight 50 patients with T2DM, 88 non-overweight patients with T2DM, 29 overweight and 100 non-overweight individuals devoid of T2DM for this study. The levels of studied adipokines were measured by enzyme-linked immunosorbent assay and correlated with clinical parameters.ResultsThe levels of MCP-1 and SFRP5 were decreased while visfatin and RBP4 levels were increased in patients with T2DM compared to those in the control individuals (P < 0.01). Among patients with T2DM, leptin and resistin levels were higher while RBP4 levels were lower in patients with overweight T2DM compared to those in patients with non-overweight T2DM (P < 0.0001, 0.019 and 0.05, respectively). Leptin and MCP-1 levels were correlated with HOMA-IR, QUICKI and HOMA-β. Leptin/MCP-1 ratio was correlated with insulin levels, HOMA-IR and HOMA-β indexes. Resistin/RBP4, visfatin/MCP-1 and MCP-1/RBP4 ratios were strongly correlated with the levels of fasting glucose, HbA1c and HOMA-β. In addition, ROC curve analyses indicated a diagnostic potential of resistin/RBP4 and MCP-1/RBP4 indexes for T2DM (AUC = 0.81 and 0.83, respectively) and β-cell function (AUC = 0.76 and 0.74, respectively).ConclusionsAdipokines (leptin, resistin, visfatin, SFRP5, MCP-1, and RBP4) are associated with overweight and T2DM and may serve as a potential prognostic marker and therapeutic intervention for overweight-related T2DM.

Seven phenolic compounds, including a new phenylethanoid, named passifoside (1), and 6 previously described compounds, syringaresinol (2), berchemol (3), threo-guaiacylglycerol (4), p-hydroxybenzaldehyde (5), 3,4,5-trimethoxyphenyl- O- β-D-glucopyranoside (6), and trans- p-coumaric acid (7), were identified from the aerial parts of Passiflora foetida. Their chemical structures were elucidated from HR-ESI-MS and NMR spectral data, and comparison with the literature. Compound 2 inhibited nitric oxide production in lipopolysaccharide-activated RAW264.7 cells, showing an IC50 value of 9.45 ± 0.33 µM. The other compounds showed either weak or no significant activity compared to L-NMMA, which was used as a positive control.

Aim: To evaluate pain relief, anti-inflammatory and hypouricemic effects of GT1 tablets on experimental animals. Method: GT1 at the doses of 22.32 g/kg/day and 66.96 g/kg/day were evaluated for its analgesic effect in three models (hot plate, pain threshold, and acetic acid-induced writhing), its chronic anti-inflammatory effect in the granulomatous reaction model, and its hypouricemic effect in potassium oxonate-induced hyperuricemic mice. Acute anti-inflammatory effects of GT1 at the doses of 11.16 g/kg/day and 33.48 g/kg/day were evaluated in rats with two models: carrageenin-induced paw edema and peritonitis. Results: GT1 prolonged the temperature reaction time on the hot plate (22.73 s and 20.37 s at both doses of 22.32 g/kg and 66.96 g/kg, respectively, compared to 16.96 s in control group), reduced the number of acid acetic-induced writhing effects, decreased the weight of granulomas, and decreased the level of acid uric in blood and urine (p < 0.05). GT1 caused a significant reduction in paw edema after subplantar injection of carrageenan in rats (p < 0.05). Moreover, there was a substantial decline of GT1 at the dose of 11.16 g/kg/day in terms of the volume and the quantity of protein in the inflammation fluid of the peritonitis model (p < 0.05). Conclusion: GT1 at both doses of 11.16 g/kg/day and 33.48 g/kg/day posed acute anti-inflammatory effects on rats. GT1 at both doses of 22.32 g/kg/day and 66.96 g/kg/day exerted analgesic, chronic anti-inflammatory and hypouricemic effects on mice.

Mục tiêu: xác định sự biến đổi và giá trị chẩn đoán của sức cơ trong mệt mỏi thể lực quân sự. Phương pháp: nghiên cứu thực nghiệm, tiến cứu, theo dõi chỉ số sức cơ cơ tối đa và sức bền cơ. Kết quả: sức cơ giảm sau mệt mỏi thể lực: sức bóp tay giảm (từ 40,69 còn 36,46kg, giảm -10,28%), sức kéo thân giảm (từ 99,70 còn 84,30kg, giảm -15,80%), sức bền tay giảm (từ 60,80 còn 37,36 giây, giảm -37,86%), sức bền chân giảm (từ 90,80 còn 52,30 giây, giảm -41,56%); sức cơ chỉ có giá trị chẩn đoán mệt mỏi thể lực tại thời điểm khi kết thúc lao động (tỷ lệ chẩn đoán đúng đạt 100%), không có giá trị chẩn đoán tại thời điểm phút 60 sau lao động. Kết luận: sức co cơ giảm trong trạng thái mệt mỏi thể lực quân sự, có giá trị chẩn đoán mệt mỏi thể lực tại thời điểm kết thúc lao động (tỷ lệ chẩn đoán đúng đạt 100%).